Impact of gemcitabine (Gem)- or capecitabine (Cape)-based chemoradiation (CRT) on health-related quality of life (HRQL) in patients with locally advanced pancreatic cancer (LAPC): Outcomes from the randomized phase II SCALOP trial.
Somnath Mukherjee
No relevant relationships to disclose
Chris Hurt
No relevant relationships to disclose
Peter Dutton
No relevant relationships to disclose
John A. Bridgewater
No relevant relationships to disclose
Thomas Crosby
No relevant relationships to disclose
Alec Mcdonald
No relevant relationships to disclose
Stephen Falk
No relevant relationships to disclose
Ross A. Abrams
No relevant relationships to disclose
Tim Maughan
No relevant relationships to disclose
Gareth Griffiths
No relevant relationships to disclose